Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia

被引:5
作者
Mueller, B. U. [1 ]
Pabst, T.
Hauser, P.
Gilliland, G.
Neuberg, D.
Tenen, D. G.
机构
[1] Univ Hosp Bern, Dept Internal Med, CH-3010 Bern, Switzerland
[2] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland
[3] Univ Hosp Bern, Dept Med Oncol, CH-3010 Bern, Switzerland
[4] Harvard Univ, Inst Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Inst Med, Boston, MA 02115 USA
关键词
PU.1; ALL; transcription factor; mutation; leukaemia;
D O I
10.1038/sj.bjc.6603198
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The transcription factor PU.I plays a crucial role during normal haematopoiesis in both myeloid cells and B-lymphocytes. Mice with a disruption in both alleles of the PU.I locus were found to lack macrophages and B cells and had delayed appearance of neutrophils. In addition, critical decrease of PU.I expression is sufficient to cause acute myeloid leukaemia (AML) and lymphomas in mice. Recently, we reported that heterozygous mutations in the PU.I gene are present in some patients with AML. Thus, we hypothesised that PU.I mutations might also contribute to the development of acute leukaemias of the B-cell lineage. Here, we screened 62 patients with B-cell acute lymphoblastic leukaemia (B-ALL) at diagnosis for genomic mutations by direct sequencing of all five exons of the PU.I gene. We found no genomic alteration of the PU.I gene suggesting that PU.I mutations are not likely to be common in B-ALL.
引用
收藏
页码:1918 / 1920
页数:3
相关论文
共 19 条
[1]
CHENG ADY, 1995, GRAVITATION COSMOLOG, V1, P1
[2]
Regulation of B lymphocyte and macrophage development by graded expression of PU.1 [J].
DeKoter, RP ;
Singh, H .
SCIENCE, 2000, 288 (5470) :1439-1441
[3]
Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain [J].
Fisher, RC ;
Olson, MC ;
Pongubala, JMR ;
Perkel, JM ;
Atchison, ML ;
Scott, EW ;
Simon, MC .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :4347-4357
[4]
HOHAUS S, 1995, MOL CELL BIOL, V15, P5830
[5]
HROMAS R, 1993, BLOOD, V82, P2998
[6]
THE MACROPHAGE AND B-CELL SPECIFIC TRANSCRIPTION FACTOR PU.1 IS RELATED TO THE ETS ONCOGENE [J].
KLEMSZ, MJ ;
MCKERCHER, SR ;
CELADA, A ;
VANBEVEREN, C ;
MAKI, RA .
CELL, 1990, 61 (01) :113-124
[7]
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities [J].
McKercher, SR ;
Torbett, BE ;
Anderson, KL ;
Henkel, GW ;
Vestal, DJ ;
Baribault, H ;
Klemsz, M ;
Feeney, AJ ;
Wu, GE ;
Paige, CJ ;
Maki, RA .
EMBO JOURNAL, 1996, 15 (20) :5647-5658
[8]
McLean TW, 1996, BLOOD, V88, P4252
[9]
MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453
[10]
SPI-1 IS A PUTATIVE ONCOGENE IN VIRALLY INDUCED MURINE ERYTHROLEUKEMIAS [J].
MOREAUGACHELIN, F ;
TAVITIAN, A ;
TAMBOURIN, P .
NATURE, 1988, 331 (6153) :277-280